ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

1-Hydroxybenzotriazole → (+/-)-2-(tert-butyldimethylsilyloxy)-N-(5-(isoquinolin-6-yl)-1,3,4-thiadiazol-2-yl)-3-phenylpropanamide

HRID 2075359
ノート
印刷プレビュー

反応式

HRID 2075359 の反応式
[Si:1]([O:8][CH:9]([CH2:13][C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1)[C:10]([OH:12])=O)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2].Cl.C(N=C=NCCCN(C)C)C.C1C=CC2N(O)N=NC=2C=1.[CH:42]1[C:51]2[C:46](=[CH:47][C:48]([C:52]3[S:56][C:55]([NH2:57])=[N:54][N:53]=3)=[CH:49][CH:50]=2)[CH:45]=[CH:44][N:43]=1.C1C2C(=CC(C(O)=O)=CC=2)C=CN=1.ClC1C=NC=C2SC(C(O)=O)=CC=12>CN(C=O)C>[Si:1]([O:8][CH:9]([CH2:13][C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1)[C:10]([NH:57][C:55]1[S:56][C:52]([C:48]2[CH:47]=[C:46]3[C:51](=[CH:50][CH:49]=2)[CH:42]=[N:43][CH:44]=[CH:45]3)=[N:53][N:54]=1)=[O:12])([C:4]([CH3:5])([CH3:6])[CH3:7])([CH3:2])[CH3:3]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 6

HCID 757711-HydroxybenzotriazoleHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 185161084-Chlorothieno[2,3-c]pyridine-2-carboxylic acidHCID 19765118(+/-)-2-(Tert-butyldimethylsilyloxy)-3-phenylpropanoic acidHCID 22128831Isoquinoline-6-carboxylic acidHCID 596944465-(Isoquinolin-6-yl)-1,3,4-thiadiazol-2-amine

生成物 1

HCID 67089607(+/-)-2-(tert-butyldimethylsilyloxy)-N-(5-(isoquinolin-6-yl)-1,3,4-thiadiazol-2-yl)-3-phenylpropanamide収率 26%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

(±)-2-(tert-Butyldimethylsilyloxy)-3-phenylpropanoic acid (1.2 g, 4.3 mmol) was taken up in 18 mL of DMF. N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine hydrochloride (1.4 g, 7.1 mmol) and HOBt (1.4 g, 11 mmol) were added. After 10 minutes, 5-(isoquinolin-6-yl)-1,3,4-thiadiazol-2-amine (0.81 g, 3.6 mmol) (prepared as shown in Scheme 5 using isoquinoline-6-carboxylic acid, commercially available from AstaTech Product List (Order Number 62874), instead of 4-chlorothieno[2,3-c]pyridine-2-carboxylic acid) was added. The mixture was stirred overnight. It was then partitioned between 50 mL of EtOAc and 50 mL of aq. NH4Cl. The aqueous portion was extracted twice with 50 mL of EtOAc. The combined organic extracts were washed with water (3×50 mL) and brine (50 mL) and dried over MgSO4. The mixture was filtered and evaporated under reduced pressure. The residue was purified by flash chromatography on silica gel (eluting with a gradient of 10% to 50% EtOAc in hexanes) to provide (±)-2-(tert-butyldimethylsilyloxy)-N-(5-(isoquinolin-6-yl)-1,3,4-thiadiazol-2-yl)-3-phenylpropanamide (0.45 g, 26%) as a yellow solid.

後処理

  1. additionwas added
  2. customIt was then partitioned between 50 mL of EtOAc and 50 mL of aq. NH4Cl
  3. extractionThe aqueous portion was extracted twice with 50 mL of EtOAc
  4. washThe combined organic extracts were washed with water (3×50 mL) and brine (50 mL)
  5. dry with materialdried over MgSO4
  6. filtrationThe mixture was filtered
  7. customevaporated under reduced pressure
  8. customThe residue was purified by flash chromatography on silica gel (
  9. washeluting with a gradient of 10% to 50% EtOAc in hexanes)

出典と根拠

ORDレコード
ord-a12f0fc83a5140bba1a99c39e1957210
出典データセット
uspto-grants-2011_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07919504B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート